Epstein-Barr Virus BZLF2 (AA 34-223) antibody (FITC)
Quick Overview for Epstein-Barr Virus BZLF2 (AA 34-223) antibody (FITC) (ABIN7141314)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 34-223
-
Virus Strain
- strain B95-8
-
Purpose
- BZLF2 Antibody, FITC conjugated
-
Cross-Reactivity
- Epstein-Barr Virus (EBV)
-
Purification
- Protein G purified
-
Purity
- >95 %
-
Immunogen
- Recombinant Epstein-Barr virus Glycoprotein 42 protein (34-223AA)
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Epstein-Barr Virus BZLF2
-
Alternative Name
- Epstein-Barr virus (strain B95-8) (HHV-4) (Herpex simplex 4) BZLF2
-
Background
-
Background: Plays a role in virion attachment to host B-lymphocytes, through binding to leukocyte antigen (HLA) class II and subsequently participates in fusion of the virion with host membranes. May act as a tropism switch that directs fusion with B-lymphocytes and inhibits fusion with epithelial cells. Additionally, hampers T-cell recognition via HLA class II molecules through steric hindrance of T-cell receptor-class II-peptide interaction.
Aliases: BZLF2Glycoprotein 42 antibody, gp42) [Cleaved into: Soluble gp42] antibody
-
UniProt
- P03205
Target
-